Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

ImClone Systems

AcroMetrix Corp. Connetics Corporation. ImClone Systems. Quintessence Biosciences. [Pg.228]

Erbitux (cetuximab chimaeric antibody raised ImClone Systems Treatment of EGF receptor-... [Pg.381]

ImClone Systems Incorporated, 180 Varick Street, New York, NY 10014, USA keren.paz imclone.com... [Pg.333]

IMC-lCll Chimeric antibody ImClone Systems Phase I... [Pg.339]

A rat anti-mouse VEGFR2 (Flkl) monoclonal antibody (DClOl) was developed by ImClone Systems (New York, NY, www.imclone.com) using conventional hybridoma technique [194] to conduct proof-of-concept studies. [Pg.339]

Marie Prewett Imclone Systems, a wholly-owned subsidiary of Eli Lilly Company, New York, NT, USA... [Pg.432]

Imclone Systems Inc. and Bristol-Myers Squibb Corp. 2004. Erbitux prescribing information. [Pg.326]

Imclone System Erbitux (Cetumimab) Chimeric Antineoplastic 2004... [Pg.419]

Erbitux Cetuximab ImClone Systems 2/2004 Advanced colorectal cancer NS0... [Pg.1423]

Fig. 8.2. The detection of membrane-bound sequences (shown for a tailed probe in 1) can be modified to considerably enhance the signal. One system (II) consists of target-specific primary probes and labeled, target-independent secondary probes. The secondary probes are specific for vector sequences of the primary probe. It is possible to have multiple primary probes, each recognizing a different region of the target. If the primary probes are M13, then all M13-specific secondary probes serve as universal probes. This patented system is marketed by ImClone Systems as AmpIiProbe. Primary probes, labeled by random priming or nick-translation, also yield hyperpolymers (III) and hence a signal amplification. The current development of branched DNA could lead to a replacement of the hyperpolymer systems. Probes with partial overlaps, e.g., obtained with nick-translation, may also form hyperpolymers. Fig. 8.2. The detection of membrane-bound sequences (shown for a tailed probe in 1) can be modified to considerably enhance the signal. One system (II) consists of target-specific primary probes and labeled, target-independent secondary probes. The secondary probes are specific for vector sequences of the primary probe. It is possible to have multiple primary probes, each recognizing a different region of the target. If the primary probes are M13, then all M13-specific secondary probes serve as universal probes. This patented system is marketed by ImClone Systems as AmpIiProbe. Primary probes, labeled by random priming or nick-translation, also yield hyperpolymers (III) and hence a signal amplification. The current development of branched DNA could lead to a replacement of the hyperpolymer systems. Probes with partial overlaps, e.g., obtained with nick-translation, may also form hyperpolymers.
Erbitux (cetuximab) Package Insert. New York ImClone Systems Inc and Princeton, NJ Bristol-Myers Squibb Company, Oct 2007. [Pg.364]

Cetuximab Erbitux Chimeric EGFR Colorectal cancer Imclone Systems... [Pg.250]

Anti-idiotype Small-cell lung cancer, Phase 111 ImClone Systems,... [Pg.546]

See other pages where ImClone Systems is mentioned: [Pg.340]    [Pg.341]    [Pg.341]    [Pg.341]    [Pg.177]    [Pg.17]    [Pg.85]    [Pg.1346]    [Pg.398]    [Pg.354]    [Pg.424]    [Pg.400]    [Pg.453]    [Pg.453]    [Pg.72]    [Pg.330]    [Pg.396]    [Pg.151]    [Pg.429]    [Pg.294]    [Pg.320]    [Pg.429]   
See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.72 , Pg.77 , Pg.179 ]



SEARCH



© 2024 chempedia.info